YAKUGAKU ZASSHI 投稿規定 - yakushi.pharm.or.jp

1 1 1 YAKUGAKU ZASSHI 1. 2. 3. 4. 4 1. Fax E mail 2.

2 MS Times New Roman 12 A4 1 YAKUGAKU ZASSHI E mail 2 250 500 3 6 3 80 3 3.

3 Supplementary materials) Supplementary materials Supplementary materials 4. Additional information for review) Additional information for review PDF 1. a, b, 2 2 aDepartment of Molecular Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University; Kita 12,Nishi 6, Kita-ku, Sapporo 060 0812, Japan:bBiomedical Research Institute, National Institute of Advanced Industri-al Science and Technology(AIST); Central 6, 1 1 1 Higashi, Tsukuba, Ibaraki 350 8566 Japan: andcDepartmentof Pharmaceutical Services, Hiroshima University Hospital.

4 1 2 3, Kasumi Minami-ku, Hiroshima 734 8551, ADP(adenosine 5 -diphosphate),AIDS(acquired immunode ciency syndrome),AMP(adenosine 5 -monophosphate or adenylic acid), ANOVA(analysis of variance),ATP(adenosine 5 -triphosphate),cAMP(adeno-sine 3 ,5 -cyclic monophosphate), cDNA(complementary DNA),CoA(coenzyme A), CYP(cytochrome P450),DNA(deoxyribonucleic acid),ED50(50 e ective dose),ESR(electron spin resonance),FAB-MS(fast atom bom-bardment mass spectrometry),FAD( avin adenine dinucleotide),GC-MS(gas chromatography-mass spectrometry),GLC(gas-liquid chromatography),GMP(guanosine 5 -monophosphate), HPLC(high-performance liquid chro-matography, high-pressure liquid chromatography),IC50(inhibitory concentration, 50 ),IR(infrared),LC(liquidchromatography), LC/MS(liquid chromatography/mass sepctrometry),LD50(50 lethal dose),mRNA(messengerRNA),MS(mass spectrum),NMR(nuclear magnetic resonance),OTC(over the counter),PCR(polymerase chainreaction),QOL(quality of life),RNA(ribonucleic acid),RT-PCR(reverse transcription polymerase chain reaction),TLC(thin-layer chromatography)

5 ,tRNA(transfer RNA),UV(ultraviolet),WHO(WorldHealthOrga nization)3. length(m, cm, mm,mm, nm, ),mass(kg,g,mg,mg, ng, pg, mol, mmol), volume(L, mL,mL),time(s, min, h, d),temperature( C, K),radiation(Bq, dpm, Gy, Sv), concentration(M,mM,mol/L, mmol/L, mg/mL,mg/mL, , (v/v), (w/v), ppm, ppb)4. 1H-NMR(CDCl3) (3H, d,J Hz), (1H, q,J Hz), (1H, m).13C-NMR(CDCl3)d: (q), (d), IR(KBr)cm 1: 1720, 1050, 910. UVlmax(EtOH)nm(e):241(10860), 288(9380).UVlmax(H2O)nm(loge):280( ).FAB-MSm/z: (Calcd for C18H20O6: ).MSm/z: 332(M ), 180, 168.[a]23D (c , MeOH). : C, ; H, ; N, Found: C, ; H, ; N, IUPAC Chem.

6 Abstr. Ring Index 6. 1 1 REFERENCES Chem. Abstr. The ACS Style Guide. A Manual for Authors and Editors REFERENCES1)Okuyama E., Gao , Yamazaki M., YAKUGAKU ZASSHI ,110,834 838(1990).2)Yamazaki M., Maebayashi Y., Iwase N., ,36, 2075 2078(1988).3)Keilhauer G., Faissner A., Schachner M.,Nature(London),316,728 730(1985).4)Kawai S., Tanaka S., ``Encyclopedia of Experimental Chemistry, Vol.

7 17, Reaction of organic compounds I,''ed. by The Chemical Society of Japan, Maruzen Co., Ltd., Tokyo, 1963, pp. 1 )Cruickshank R., Duguid I. P., Marmion B. P., Swain R. H. A., ``Medical Microbiology,'' 12nd ed., Vol. III,Churchill Livingstone, New York, )Szejtli J., ``Cyclodextrin Technology,'' ed. by Davis J. E. D., Kluwer Academic, Dordrecht, )Tokuda H., Ichiishi E., Onozuka M., Yamaguchi S., ``Biology of Nitric Oxide, Part 6,'' Vol. I Chap. 2, ed. byMoncada S., Tada N., Maeda H., Portland Press, London, 1998, pp. 185 )Brunner A., Greune H., Patent 1910462(1933)[Chem. Abstr.]

8 ,27, 4092 4096(1993)].9)Mochizuki M., Inami K., Abstracts of papers, the 119th Annual Meeting of the Pharmaceutical Society ofJapan, Tokushima, March 1999, No. 2, p. )International Organization for Standardization. ``How ISO develops standards.'': , cited 25 August, 2008. rst middle name 3 3 X Cambridge Crys-tallographic Data Centre(CCDC crystal data(unit cell parameters, space group, Z density),R-factor Atomic coordinates Bond lengths and angles, thermal parameters, torsion angles CCDC DDBJ, GenBank EMBL accession number accession number Natural Products and Crude Extract Materials.

9 NP/CEM NP/CEM Guidelines/Checklist for authors submitting papers dealing with Natural Products and Crude Extract Materials(NP/CEM Guidelines/Checklist 1. #4 2. Con ict of Interest.)

10 COI 1) 2) 3) 4) 5) 1 AB 2 CD 3 EF 4 GH XX 5 IJ 6 KL YY 7 JP Patent 12345 MN 8 ZZ OP 9 1.